• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞上S1PR2的激活以及在小胆管消失综合征中的肝细胞S1PR2/RhoA/ROCK1/MLC2通路

Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.

作者信息

Miyagawa-Hayashino Aya, Imura Tetsuya, Takezawa Toshiaki, Hirai Maki, Shibata Saya, Ogi Hiroshi, Tsujikawa Takahiro, Konishi Eiichi

机构信息

Department of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Faculty of Pharmacy, Chiba Institute of Science, Chiba, Japan.

出版信息

PLoS One. 2025 Jan 24;20(1):e0317568. doi: 10.1371/journal.pone.0317568. eCollection 2025.

DOI:10.1371/journal.pone.0317568
PMID:39854311
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11760576/
Abstract

Immunologic bile duct destruction is a pathogenic condition associated with vanishing bile duct syndrome (VBDS) after liver transplantation and hematopoietic stem-cell transplantation. As the bile acid receptor sphingosine 1-phosphate receptor 2 (S1PR2) plays a critical role in recruitment of bone marrow-derived monocytes/macrophages to sites of cholestatic liver injury, S1PR2 expression was examined using cultured macrophages and patient tissues. Bile canaliculi destruction precedes intrahepatic ductopenia; therefore, we focused on hepatocyte S1PR2 and the downstream RhoA/Rho kinase 1 (ROCK1) signaling pathway and bile canaliculi alterations using three-dimensional hepatocyte culture models that form obvious bile canaliculus-like networks. Multiplex immunohistochemistry revealed increased numbers of S1PR2+CD45+CD68+FCN1+ inflammatory macrophages and S1PR2+CD45+CD68+MARCO+ Kupffer cells in liver tissues showing ductopenia due to graft-versus-host disease and rejection post-liver transplant compared with normal liver. Macrophage expression of proinflammatory cytokines, including MCP1, was reduced following S1PR2 inhibition. Taurocholic acid and S1P2 agonist induced hepatocyte S1PR2 and reduced RhoA/ROCK1 expression, resulting in bile canaliculi dilatation. S1PR2 inhibition reversed the effect on RhoA/ROCK1 expression, resulting in maintenance of bile canaliculi through myosin light chain 2 (MLC2) phosphorylation. Activation of S1PR2 on macrophages and S1PR2 on hepatocytes may disrupt bile canaliculi dynamics in VBDS under regulation by RhoA/ROCK1 through MLC2 phosphorylation.

摘要

免疫性胆管破坏是一种与肝移植和造血干细胞移植后出现的胆管消失综合征(VBDS)相关的致病状态。由于胆汁酸受体鞘氨醇-1-磷酸受体2(S1PR2)在骨髓来源的单核细胞/巨噬细胞募集至胆汁淤积性肝损伤部位的过程中起关键作用,因此利用培养的巨噬细胞和患者组织对S1PR2表达进行了检测。胆小管破坏先于肝内胆管减少;因此,我们利用形成明显胆小管样网络的三维肝细胞培养模型,重点研究了肝细胞S1PR2及下游RhoA/Rho激酶1(ROCK1)信号通路和胆小管改变。多重免疫组化显示,与正常肝脏相比,因移植物抗宿主病和肝移植后排斥反应导致胆管减少的肝组织中,S1PR2+CD45+CD68+FCN1+炎性巨噬细胞和S1PR2+CD45+CD68+MARCO+库普弗细胞数量增加。S1PR2抑制后,包括MCP1在内的促炎细胞因子的巨噬细胞表达降低。牛磺胆酸和S1P2激动剂诱导肝细胞S1PR2表达并降低RhoA/ROCK1表达,导致胆小管扩张。S1PR2抑制可逆转对RhoA/ROCK1表达的影响,通过肌球蛋白轻链2(MLC2)磷酸化维持胆小管结构。巨噬细胞上S1PR2的激活和肝细胞上S1PR2的激活可能会在RhoA/ROCK1通过MLC2磷酸化的调控下破坏VBDS中胆小管的动态变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/c4a293b3231d/pone.0317568.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/5f7c14a4c3cc/pone.0317568.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/ad7891450774/pone.0317568.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/5d66cf82fac1/pone.0317568.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/b3f20e996901/pone.0317568.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/c4a293b3231d/pone.0317568.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/5f7c14a4c3cc/pone.0317568.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/ad7891450774/pone.0317568.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/5d66cf82fac1/pone.0317568.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/b3f20e996901/pone.0317568.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54e1/11760576/c4a293b3231d/pone.0317568.g005.jpg

相似文献

1
Activation of S1PR2 on macrophages and the hepatocyte S1PR2/RhoA/ROCK1/MLC2 pathway in vanishing bile duct syndrome.巨噬细胞上S1PR2的激活以及在小胆管消失综合征中的肝细胞S1PR2/RhoA/ROCK1/MLC2通路
PLoS One. 2025 Jan 24;20(1):e0317568. doi: 10.1371/journal.pone.0317568. eCollection 2025.
2
S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization.S1PR2/RhoA/ROCK1 通路通过诱导肠道血管内皮屏障损伤和 M1 巨噬细胞极化促进炎症性肠病。
Biochem Pharmacol. 2022 Jul;201:115077. doi: 10.1016/j.bcp.2022.115077. Epub 2022 May 10.
3
Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs.Rho激酶/肌球蛋白轻链激酶通路在胆汁淤积性药物诱导的胆小管动力学损伤中起关键作用。
Sci Rep. 2016 May 12;6:24709. doi: 10.1038/srep24709.
4
The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice.1-磷酸鞘氨醇受体2在胆汁酸诱导的小鼠胆管细胞增殖及胆汁淤积性肝损伤中的作用
Hepatology. 2017 Jun;65(6):2005-2018. doi: 10.1002/hep.29076. Epub 2017 Apr 28.
5
Sphingosine-1-phosphate/S1PR2-mediated signaling triggers Smad1/5/8 phosphorylation and thereby induces Runx2 expression in osteoblasts.鞘氨醇-1-磷酸/S1PR2介导的信号传导触发Smad1/5/8磷酸化,从而诱导成骨细胞中Runx2的表达。
Bone. 2016 Dec;93:1-11. doi: 10.1016/j.bone.2016.09.003. Epub 2016 Sep 6.
6
S1PR2 antagonist ameliorate high glucose-induced fission and dysfunction of mitochondria in HRGECs via regulating ROCK1.S1PR2拮抗剂通过调节ROCK1改善高糖诱导的人视网膜微血管内皮细胞线粒体分裂和功能障碍。
BMC Nephrol. 2019 Apr 18;20(1):135. doi: 10.1186/s12882-019-1323-0.
7
Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice.鞘氨醇-1-磷酸受体-2 缺陷导致载脂蛋白 E 缺陷小鼠巨噬细胞促炎活性和动脉粥样硬化的抑制。
J Clin Invest. 2010 Nov;120(11):3979-95. doi: 10.1172/JCI42315. Epub 2010 Oct 18.
8
PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathway.蛋白激酶 C-β 通过调控 RhoA/Rho 激酶/肌球蛋白轻链 2 通路加重高糖环境下体外血脑屏障损伤。
J Cereb Blood Flow Metab. 2013 Dec;33(12):1928-36. doi: 10.1038/jcbfm.2013.151. Epub 2013 Aug 21.
9
Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.外源性 S1P 通过 S1P 受体 2 通过Src-RhoA-ROCK-YAP 通路诱导肝星状细胞中 CTGF 的表达。
Mol Biol Rep. 2024 Sep 2;51(1):950. doi: 10.1007/s11033-024-09868-w.
10
Rho kinase signaling pathways during stretch in primary alveolar epithelia.原代肺泡上皮细胞牵张过程中的 Rho 激酶信号通路。
Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L992-1002. doi: 10.1152/ajplung.00175.2011. Epub 2012 Jan 27.

引用本文的文献

1
Biological Actions of Bile Acids via Cell Surface Receptors.胆汁酸通过细胞表面受体的生物学作用。
Int J Mol Sci. 2025 May 22;26(11):5004. doi: 10.3390/ijms26115004.
2
Low density of intratumoral M1-macrophage infiltration may correlate with worse prognosis in low-grade early-stage uterine endometrioid carcinoma.肿瘤内M1巨噬细胞浸润密度低可能与低级别早期子宫内膜样腺癌的预后较差相关。
Gynecol Oncol Rep. 2025 May 10;59:101758. doi: 10.1016/j.gore.2025.101758. eCollection 2025 Jun.

本文引用的文献

1
Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions.牛磺胆酸在胆汁淤积条件下通过 S1PR2/p38 MAPK/YAP 信号促进肝星状细胞激活。
Clin Mol Hepatol. 2023 Apr;29(2):465-481. doi: 10.3350/cmh.2022.0327. Epub 2023 Feb 20.
2
S1PR2/RhoA/ROCK1 pathway promotes inflammatory bowel disease by inducing intestinal vascular endothelial barrier damage and M1 macrophage polarization.S1PR2/RhoA/ROCK1 通路通过诱导肠道血管内皮屏障损伤和 M1 巨噬细胞极化促进炎症性肠病。
Biochem Pharmacol. 2022 Jul;201:115077. doi: 10.1016/j.bcp.2022.115077. Epub 2022 May 10.
3
HepG2-NIAS cells, a new subline of HepG2 cells that can enhance not only CYP3A4 activity but also expression of drug transporters and form bile canaliculus-like networks by the oxygenation culture via a collagen vitrigel membrane.
HepG2-NIAS 细胞,一种新的 HepG2 细胞亚系,通过胶原 vitrigel 膜的氧合培养不仅可以增强 CYP3A4 活性,还可以增强药物转运体的表达,并形成胆小管样网络。
J Toxicol Sci. 2022;47(1):39-50. doi: 10.2131/jts.47.39.
4
Human Liver Macrophage Subsets Defined by CD32.人肝巨噬细胞亚群的 CD32 定义。
Front Immunol. 2020 Sep 23;11:2108. doi: 10.3389/fimmu.2020.02108. eCollection 2020.
5
Knockdown Promotes Migration and Invasion in Multiple Myeloma Cells via NF-κB Activation.敲低通过激活核因子κB促进多发性骨髓瘤细胞的迁移和侵袭。
Cancer Manag Res. 2020 Aug 26;12:7857-7865. doi: 10.2147/CMAR.S237330. eCollection 2020.
6
Blocking sphingosine 1-phosphate receptor 2 accelerates hepatocellular carcinoma progression in a mouse model of NASH.阻断鞘氨醇 1-磷酸受体 2 可加速 NASH 小鼠模型中的肝细胞癌进展。
Biochem Biophys Res Commun. 2020 Oct 1;530(4):665-672. doi: 10.1016/j.bbrc.2020.07.099. Epub 2020 Aug 4.
7
Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.鞘氨醇激酶和鞘氨醇-1-磷酸受体信号通路在炎症性胃肠道疾病和癌症中的作用:一个新的治疗靶点。
Pharmacol Ther. 2020 Mar;207:107464. doi: 10.1016/j.pharmthera.2019.107464. Epub 2019 Dec 18.
8
A human liver cell atlas reveals heterogeneity and epithelial progenitors.人类肝脏细胞图谱揭示了其异质性和上皮祖细胞。
Nature. 2019 Aug;572(7768):199-204. doi: 10.1038/s41586-019-1373-2. Epub 2019 Jul 10.
9
Serine Threonine Kinase 17A Maintains the Epithelial State in Colorectal Cancer Cells.丝氨酸苏氨酸激酶 17A 维持结直肠癌细胞的上皮状态。
Mol Cancer Res. 2019 Apr;17(4):882-894. doi: 10.1158/1541-7786.MCR-18-0990. Epub 2019 Jan 17.
10
Sphingosine 1-phosphate (S1P) reduces hepatocyte growth factor-induced migration of hepatocellular carcinoma cells via S1P receptor 2.鞘氨醇 1-磷酸(S1P)通过 S1P 受体 2 减少肝细胞生长因子诱导的肝癌细胞迁移。
PLoS One. 2018 Dec 13;13(12):e0209050. doi: 10.1371/journal.pone.0209050. eCollection 2018.